Antiviral drugs market driven by increase in healthcare expenditure

The market of antiviral drugs is segmented on the basis of products, such as Hepatitis-C antivirals, HIV antivirals, Herpes antivirals, Hepatitis-B antivirals, Influenza antivirals and others. The market is also segmented on the basis of enzyme specific actions, such as DNA polymerase inhibitors, NS3 Protease inhibitors, reverse transcriptase inhibitors and others. The market is also segmented on the basis of geography, such as North America, Europe, Asia-Pacific and Rest of the World (RoW). The U.S. is the biggest market for antiviral drugs, followed by the U.K. and Japan. However, Asia-Pacific and African regions of the world are considered as the most promising markets in the forecast period. Virus is a micro-infectious agent that replicates only in the living cells,which results in prevalence of disease. Antiviral drugs are a class of medications that are specifically used to treat the viral infections. Usually, antivirals inhibit the growth of pathogens.

Download free exclusive Brochure of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2306

Some of the key factors driving the antiviral drugs market are strong R&D activities, increase in healthcare expenditure, increased prevalence of the life-threatening viral diseases and increase in the public awareness. According to WHO, as of October 2013, there are around 35.3 million people in the world, infected with HIV. Hence, increased viral infection incidences is one of the prominent factors that drives the market growth. Due to strong R&D activities, newer and advanced formulations and treatments, such as combination therapy, vaccines and others, are being introduced in the market. Thus, strong R&D is one of the key factors in the market growth. On the other hand, high cost of R&D and therapy, high risk of failure and government austerity are some of threats expected to hinder the growth of market.

Some of the major players operating in this market includes GlaxoSmithKline, plc. Abbott Laboratories, AstraZeneca AB, BoehringerIngelheim Corporation, Novartis International AG, Merck and Co. Inc., Johnson & Johnson amongst others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:

North America
Asia Pacific
Europe
Rest of the World

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.